Clinical trial · Observational
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
Supplemental Screening for Breast Cancer With Abbreviated Breast MR for Black Women With Increased Breast Density
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breast densities 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant discharge. Investigators will identify these patients EPIC database utilizing the date of their last mammogram. Interested patients may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fast Breast Abbreviated Magnetic Renounce Imaging | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Breast cancer detection and false negative rates of supplemental screening with AB-MR
- timeFrame
- Through the completion of study, an average of 4 year
- description
- The cancer detection and false negative rate (per 1000 women screened) of supplemental screening with AB-MR in this population will be measured as well as the stage, grade and subtype of detected and non-detected breast cancers.
- measure
- Additional screening outcomes
- timeFrame
- Through the completion of study, an average of 4 year
- description
- The rates of false positive exams prompting biopsy and short term follow-up recommendations after AB-MR will be evaluated.
Secondary outcomes (1)
- measure
- The screening outcomes of AB-MR in this population of Black women will be compared to a similar population of Caucasian women undergoing AB-MR.
- timeFrame
- Through the completion of study, an average of 4 year
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. African American female 2. Negative DBT examination within eleven months prior to recruitment 3. Heterogeneoulsy and Extremely breast densities 4. Clinically asymptomatic- no palpable masses or focal thickening, etc. Exclusion Criteria: 1. Patients who are pregnant and lactating 2. Patient who have not had a mammogram (DBT) in the past 11months 3. Patients who are unwilling or unable to provide written informed consent 4. Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.) 5. Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections) 6. Patients who are unable to received an MRI with Gadolinium contrast 7. Patients who have not had an MRI of the breast with the past year
References
Publications (0)
Data not yet available